Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
23 December 2020Website:
http://gbs.incNext earnings report:
15 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Wed, 03 Jul 2024 18:10:00 GMTDividend
Analysts recommendations
Institutional Ownership
INBS Latest News
NEW YORK, June 27, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the expansion of its customer network within the UK retail sector. This includes the adoption of INBS' Intelligent Fingerprinting Drug Screening System by three prominent UK retailers, among the largest and most recognized in the country.
NEW YORK, June 06, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that its management team will participate in the Sidoti Small-Cap Conference being held virtually June 12-13, 2024.
NEW YORK, May 23, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today unveiled key performance indicators from its United Kingdom operations. These indicators have contributed to the Company's growth as the drug screening industry continues to combat drug test cheating and searches for simpler, faster, non-invasive, and more cost-effective solutions.
NEW YORK, March 01, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that it will present at the Emerging Growth Conference on March 6, 2024. INBS will provide an update on the Company's growth and financial performance in 2023, among other topics.
Intelligent Bio Solutions (NASDAQ: INBS ) stock is falling on Monday following the release of the medical technology company's earnings report for its fiscal second quarter of 2024. The Intelligent Bio Solutions earnings release includes adjusted earnings per share of -$2.07.
NEW YORK, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that it will present at the Emerging Growth Conference on December 7, 2023. The Company will provide insight into the Company's unique proprietary Intelligent Fingerprinting Drug Screening System, among other topics.
What type of business is Intelligent Bio Solutions?
Intelligent Bio Solutions Inc., a life sciences company, developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
What sector is Intelligent Bio Solutions in?
Intelligent Bio Solutions is in the Healthcare sector
What industry is Intelligent Bio Solutions in?
Intelligent Bio Solutions is in the Medical Devices industry
What country is Intelligent Bio Solutions from?
Intelligent Bio Solutions is headquartered in United States
When did Intelligent Bio Solutions go public?
Intelligent Bio Solutions initial public offering (IPO) was on 23 December 2020
What is Intelligent Bio Solutions website?
https://gbs.inc
Is Intelligent Bio Solutions in the S&P 500?
No, Intelligent Bio Solutions is not included in the S&P 500 index
Is Intelligent Bio Solutions in the NASDAQ 100?
No, Intelligent Bio Solutions is not included in the NASDAQ 100 index
Is Intelligent Bio Solutions in the Dow Jones?
No, Intelligent Bio Solutions is not included in the Dow Jones index
When does Intelligent Bio Solutions report earnings?
The next expected earnings date for Intelligent Bio Solutions is 15 August 2024